13th July 2020, the Cambridgeshire based DVT prevention device company RBR Active are pleased to announce that they are working with SehaMed Global to take their clinically researched, trialled, MHRA approved Deep Vein Thrombosis prevention device to the global medical market.

For more information please see our release below and for any media comments please email media@rbractive.com